Research programme: serotonin 6 receptor antagonists - WyethAlternative Names: 321348; 5-HT6 receptor antagonists - Wyeth; WAY-101
Latest Information Update: 27 Oct 2010
At a glance
- Originator Wyeth
- Developer Pfizer
- Class Small molecules
- Mechanism of Action Serotonin 6 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Alzheimer's disease